Articles from Counsel Health

Counsel Health, the AI-native primary care company, today announced the launch of its weight management program, bringing its comprehensive care model to obesity treatment. As part of this launch, Counsel is working with LillyDirect, Eli Lilly and Company’s direct to consumer digital pharmacy.

Counsel Health, the AI-native primary care company, today announced its participation in the Centers for Medicare & Medicaid Services (CMS) Innovation Center’s Advancing Chronic Care with Effective Scalable Solutions (ACCESS) Model under the early cardio-kidney-metabolic (eCKM) track.

Counsel Health, the AI-enabled, physician-supervised primary care company supporting members through a messaging-based interface, today announced the launch of Counsel Studio, a new deployment platform that enables healthcare organizations to embed personalized, AI-enabled care directly into their existing digital experiences.

Counsel Health, the AI-enabled, physician-supervised primary care company delivering care through a messaging-based interface, today announced its clinical expansion into two new treatment verticals: lifestyle and chronic conditions. This expansion marks a meaningful step in Counsel’s evolution, extending its ability to deliver AI-enabled longitudinal care across a broader spectrum of needs, further establishing the company as the trusted provider supporting patients' holistic health journey. Counsel’s expanded clinical services will initially focus on lifestyle conditions, such as hair loss, acne, and sexual health, and will broaden care throughout 2026 to include chronic conditions, such as hypertension, high cholesterol, and obesity.

Counsel Health today announced the launch of its next-generation AI care platform, built to serve as the responsible front door to healthcare. Backed by a $25 million Series A led by Andreessen Horowitz (a16z) and GV. Counsel combines the immediacy of AI with the oversight of licensed physicians to deliver care that is faster, safer, and more cost-effective at scale. This follows the company’s $11 million Seed raise, led by a16z in October 2024, underscoring the need for a healthcare experience that combines medical AI with in-house doctors.